DE2246013A1 - Verfahren zur herstellung von poroesen tabletten - Google Patents

Verfahren zur herstellung von poroesen tabletten

Info

Publication number
DE2246013A1
DE2246013A1 DE2246013A DE2246013A DE2246013A1 DE 2246013 A1 DE2246013 A1 DE 2246013A1 DE 2246013 A DE2246013 A DE 2246013A DE 2246013 A DE2246013 A DE 2246013A DE 2246013 A1 DE2246013 A1 DE 2246013A1
Authority
DE
Germany
Prior art keywords
tablets
tablet
excipient
urethane
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2246013A
Other languages
German (de)
English (en)
Inventor
Helmut Dr Rer Nat Heinemann
Werner Dr Rer Nat Rothe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE2246013A priority Critical patent/DE2246013A1/de
Priority to US395796A priority patent/US3885026A/en
Priority to GB4318773A priority patent/GB1381588A/en
Priority to IT7328973A priority patent/IT998618B/it
Priority to CH1329273A priority patent/CH579394A5/xx
Priority to FR7333392A priority patent/FR2199973B1/fr
Priority to AT806973A priority patent/AT324568B/de
Priority to SE7312753A priority patent/SE395366B/xx
Priority to JP48106458A priority patent/JPS4969819A/ja
Publication of DE2246013A1 publication Critical patent/DE2246013A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01—Wetting, emulsifying, dispersing, or stabilizing agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE2246013A 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten Pending DE2246013A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE2246013A DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten
US395796A US3885026A (en) 1972-09-20 1973-09-10 Preparation of porous tablets
GB4318773A GB1381588A (en) 1972-09-20 1973-09-14 Process for the preparation of porous tablets
IT7328973A IT998618B (it) 1972-09-20 1973-09-17 Procedimento per la produzione di pastiglie porose
CH1329273A CH579394A5 (fr) 1972-09-20 1973-09-17
FR7333392A FR2199973B1 (fr) 1972-09-20 1973-09-18
AT806973A AT324568B (de) 1972-09-20 1973-09-19 Verfahren zur herstellung von porosen tabletten
SE7312753A SE395366B (sv) 1972-09-20 1973-09-19 Forfarande for framstellning av porosa tabletter
JP48106458A JPS4969819A (fr) 1972-09-20 1973-09-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2246013A DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten

Publications (1)

Publication Number Publication Date
DE2246013A1 true DE2246013A1 (de) 1974-03-28

Family

ID=5856791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2246013A Pending DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten

Country Status (9)

Country Link
US (1) US3885026A (fr)
JP (1) JPS4969819A (fr)
AT (1) AT324568B (fr)
CH (1) CH579394A5 (fr)
DE (1) DE2246013A1 (fr)
FR (1) FR2199973B1 (fr)
GB (1) GB1381588A (fr)
IT (1) IT998618B (fr)
SE (1) SE395366B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561A1 (de) * 1975-12-16 1977-06-30 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2744493A1 (de) * 1976-10-06 1978-04-13 Wyeth John & Brother Ltd Geformter traeger fuer chemikalien und/oder pharmaka
DE3734796A1 (de) * 1986-10-14 1988-04-21 Beaufour Lab Verfahren zur herstellung von loeslichen und/oder zerteilbaren tabletten und nach diesem verfahren erhaltene tabletten

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078044A (en) * 1975-03-10 1978-03-07 University Of Southern California Process for the catalytic oxidation of ammonia and methane to hydrogen cyanide
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4568547A (en) * 1979-08-30 1986-02-04 Herschler R J Solid pharmaceutical compositions comprising MSM and their production
US4883182A (en) * 1985-05-31 1989-11-28 Hughes Raymond J Tamper evident capsule and insert device
ES2087558T3 (es) * 1991-12-20 1996-07-16 Pfizer Medios de administracion conformados porosos, y procedimiento de produccion de los mismos.
EP0620728B1 (fr) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation de comprimes a efficacite amelioree
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
WO1996008979A1 (fr) 1994-09-22 1996-03-28 Quadrant Holdings Cambridge Limited Compositions de rehydratation et de nutrition a utiliser pendant une activite sportive, et leurs procedes de preparation
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
JP3797387B2 (ja) * 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6294151B1 (en) 1996-08-13 2001-09-25 Kyowa Hakko Kogyo, Co., Ltd. Isotopic urea tablets
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
IL143071A0 (en) 1998-11-10 2002-04-21 Teva Pharma Dispersible compositions containing l-dopa ethyl ester
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
DK1280520T4 (en) 2000-05-10 2018-06-25 Novartis Ag Phospholipid based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US20030185886A1 (en) * 2000-05-26 2003-10-02 Hanmi Pharm. Co., Ltd. Process for the preparation of rapidly disintegrating tablet
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
GB0028709D0 (en) * 2000-11-24 2001-01-10 S P A Process
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
IL157320A0 (en) * 2001-02-08 2004-02-19 Pharmacia Corp Rapid-onset medicament for the treatment of sexual dysfunction
CN1494419A (zh) * 2001-03-06 2004-05-05 协和发酵工业株式会社 口腔内快速崩解制剂
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
EP1458360B1 (fr) 2001-12-19 2011-05-11 Novartis AG Administration pulmonaire d'aminoglycosides
CA2480377A1 (fr) * 2002-03-26 2003-10-09 Teva Pharmaceutical Industries Ltd. Microparticules medicamenteuses
MXPA05003512A (es) * 2002-10-04 2005-06-03 Pharmacia Corp Composiciones y metodos para el tratamiento de la disfuncion sexual.
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CN1819819B (zh) * 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US8802145B2 (en) * 2004-10-28 2014-08-12 Pantec Ag Highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
WO2009002084A2 (fr) * 2007-06-27 2008-12-31 Hanmi Pharm. Co., Ltd. Procédé de préparation d'une formulation à désagrégation rapide pour l'administration par voie orale et appareil de préparation et de conditionnement correspondant
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
US20090110716A1 (en) * 2007-10-31 2009-04-30 Frank Bunick Orally disintegrative dosage form
EP2457561A4 (fr) * 2009-07-06 2014-03-05 Kyorin Seiyaku Kk Comprimé ayant une structure creuse
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8807979B2 (en) 2009-09-24 2014-08-19 Mcneil-Ppc, Inc. Machine for the manufacture of dosage forms utilizing radiofrequency energy
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
CA2782285A1 (fr) 2009-12-02 2011-06-09 Luigi Mapelli Microcapsules de fexofenadine et compositions les contenant
WO2011085181A1 (fr) * 2010-01-08 2011-07-14 Eurand, Inc. Composition de topiramate à goût masqué et comprimé à délitement oral l'incluant
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
RU2712267C2 (ru) 2014-01-10 2020-01-28 Джонсон энд Джонсон Консьюмер Инк. Способ изготовления таблеток с использованием радиочастотного излучения и частиц с поглощающим покрытием
IL262312B (en) 2016-04-21 2022-08-01 Astrazeneca Ab Tablets containing ticagrelor that disintegrate upon oral administration and a process for their preparation
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1742515A (en) * 1924-10-08 1930-01-07 Ambrose J Mandell Method of making porous objects
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US3175521A (en) * 1961-02-23 1965-03-30 Schering Corp Apparatus for punching miniature tablets
US3371984A (en) * 1963-09-06 1968-03-05 Colgate Palmolive Co Air freshener
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3450494A (en) * 1967-07-18 1969-06-17 Conrad J Gaiser Amorphous sodium silicate having inherent binding properties and method of producing same
US3639286A (en) * 1968-05-28 1972-02-01 Mario Ballestra Synthetic detergent in bar or cake form and the method to manufacture same
GB1303102A (fr) * 1969-01-16 1973-01-17
US3719599A (en) * 1969-11-25 1973-03-06 Lepetit Spa Solid lubricant composition and method of preparation
LU60170A1 (fr) * 1970-01-09 1971-11-18
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
US3739048A (en) * 1971-05-26 1973-06-12 Sumitomo Electric Industries Method of granulating powder
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561A1 (de) * 1975-12-16 1977-06-30 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2744493A1 (de) * 1976-10-06 1978-04-13 Wyeth John & Brother Ltd Geformter traeger fuer chemikalien und/oder pharmaka
DE3734796A1 (de) * 1986-10-14 1988-04-21 Beaufour Lab Verfahren zur herstellung von loeslichen und/oder zerteilbaren tabletten und nach diesem verfahren erhaltene tabletten

Also Published As

Publication number Publication date
CH579394A5 (fr) 1976-09-15
FR2199973A1 (fr) 1974-04-19
SE395366B (sv) 1977-08-15
AT324568B (de) 1975-09-10
US3885026A (en) 1975-05-20
IT998618B (it) 1976-02-20
GB1381588A (en) 1975-01-22
JPS4969819A (fr) 1974-07-05
FR2199973B1 (fr) 1979-01-05

Similar Documents

Publication Publication Date Title
DE2246013A1 (de) Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) Verfahren zur Herstellung von porösen Tabletten
EP0078430B1 (fr) Procédé de fabrication de préparations pharmaceutiques solides à libération rapide de dihydropyridines
KR930007251B1 (ko) 안정한 니코란딜 제제의 제조방법
DE3420283A1 (de) Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung
DE60036205T2 (de) Granulat bestehend aus Stärke und Laktose
DD292837A5 (de) Verfahren zur herstellung von cholestyramin-tabletten
EP0122574B1 (fr) Pastille divisible à libération retardée de l'ingrédient actif et procédé pour la fabrication de celle-ci
DE3505433A1 (de) Direkttablettierhilfsmittel
DE4122217A1 (de) Verfahren zur herstellung mechanisch stabiler, gut zerfallender komprimate aus kleinen wirkstoffhaltigen formkoerpern
DE19628617A1 (de) Direkttablettierhilfsmittel
DE69913958T2 (de) Nichtkristalline feste dispergierende Zusammensetzung mit Cefuroximaxetil
US4203997A (en) Directly-pressable ascorbic acid-containing granulates
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
US20020142044A1 (en) Pharmaceutical dosage forms with enhanced cohesive and compressiblity properties
CH643737A5 (en) Preparation of a solid material composed of ergot peptide alkaloids and polyvinylpyrrolidone
US4645664A (en) Microporous powder form polylactides
DE04078149T1 (de) Stabile feste Zusammensetzung von Enalaprilsalz und dessen Herstellung
DE2415936C2 (fr)
DE3142853C2 (fr)
US3493659A (en) Compositions and process for the production thereof
EP1037613B1 (fr) Procede pour produire des formulations pharmaceutiques contenant un extrait
DE3045488A1 (de) Verfahren zur herstellung von stabilisierten kallikreinhaltigen tabletten
EP0223033B1 (fr) Procédé pour le séchage et la granulation simultanés d'extraits du sang de veau déprotéiné, granulé obtenu par ce procédé et son utilisation pour la fabrication de préparations pharmaceutiques
DE3942131C2 (de) Pharmazeutisches Trimebutin-haltiges Präparat mit verlängerter Wirkstoff-Freisetzung und Verfahren zur Herstellung

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination